当前位置:首页 - 行情中心 - 派林生物(000403) - 财务分析

派林生物

(000403)

  

流通市值:147.69亿  总市值:149.21亿
流通股本:9.41亿   总股本:9.50亿

派林生物(000403)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润3.57亿元,每股收益0.38元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益801916.68万元,未分配利润237381.97万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产957519.12万元,负债155602.44万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入1,618,146,526.33986,481,770.22374,649,641.982,654,684,638.93
营业总成本1,204,150,334.5711,561,568.4276,480,817.31,815,728,401.84
其他经营收益
营业利润431,462,687.63285,726,732.32109,867,387.81880,313,029.04
利润总额406,936,999.45268,930,121.96103,362,342.57852,778,057.65
净利润357,497,339.78235,916,844.5588,939,547.68745,042,150.36
每股收益
其他综合收益-6,950.72-2,537.11-707.317,688.42
综合收益总额357,490,389.06235,914,307.4488,938,840.37745,049,838.78
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计3,775,000,285.13,320,695,525.693,469,649,834.083,578,948,533.75
非流动资产:
非流动资产合计5,800,190,956.525,760,600,5975,727,051,004.775,667,320,831.51
资产总计9,575,191,241.629,081,296,122.699,196,700,838.859,246,269,365.26
流动负债:
流动负债合计1,286,570,539.25904,037,502.46827,866,779.33956,971,752.28
非流动负债:
非流动负债合计269,453,897.51279,717,896.99362,392,583.8371,794,977.63
负债合计1,556,024,436.761,183,755,399.451,190,259,363.131,328,766,729.91
所有者权益(或股东权益):
归属于母公司股东权益合计8,025,948,717.197,904,564,897.898,013,739,259.897,924,650,751.55
股东权益合计8,019,166,804.867,897,540,723.248,006,441,475.727,917,502,635.35
负债和股东权益合计9,575,191,241.629,081,296,122.699,196,700,838.859,246,269,365.26
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计1,675,909,944.71986,437,123.76504,109,212.862,548,993,766.25
经营活动现金流出小计1,772,396,789.81,179,101,021.55619,948,561.152,227,203,359.98
经营活动产生的现金流量净额-96,486,845.09-192,663,897.79-115,839,348.29321,790,406.27
投资活动产生的现金流量:
投资活动现金流入小计934,875,655.73700,121,187.6157,629,268.491,910,661,561.31
投资活动现金流出小计1,510,279,572.611,038,057,408.07604,346,822.662,246,597,592.07
投资活动产生的现金流量净额-575,403,916.88-337,936,220.46-546,717,554.17-335,936,030.76
筹资活动产生的现金流量:
筹资活动现金流入小计534,368,741.72258,151,722.36120,293,204.46586,078,943.6
筹资活动现金流出小计609,997,665.17491,747,782.81112,173,983.75679,823,658.23
筹资活动产生的现金流量净额-75,628,923.45-233,596,060.458,119,220.71-93,744,714.63
汇率变动对现金及现金等价物的影响-23,583.88-8,285.78-2,924.08-28,116.37
现金及现金等价物净增加额-747,543,269.3-764,204,464.48-654,440,605.83-107,918,455.49
期末现金及现金等价物余额572,817,285.31556,156,090.13665,919,948.781,320,360,554.61
补充资料:
现金及现金等价物的净增加额--764,204,464.48--107,918,455.49
最新报告期:2025-09-05
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中信证券陈竹,王凯旋,韩世通0.901.121.232025-09-05
东方证券伍云飞,赵博宇0.871.051.252025-09-02
华源证券刘闯,李强0.770.860.962025-08-28
野村东方国际证券孔令岩0.931.071.222025-08-27
TOP↑